Biomérieux Clinical Diagnostics (Ivd)

a world leader in in vitro diagnostics for more than 55 years, biomérieux is present in 43 countries and serves more than 160 countries through a large network of distributors. in 2018, biomérieux's sales reached € 2.4 billion, more than 90% of which was generated internationally. biomérieux offers diagnostic solutions (systems, reagents, software and services) that determine the origin of a disease to improve the health of patients. world leader in microbiology, specialized in immunoassays and leading pioneer in the syndromic molecular approach, the company is mobilized on major public health issues in the field of infectious diseases, such as antibiotic resistance, sepsis and respiratory infections.